Filing Details

Accession Number:
0001140361-15-029008
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-07-29 17:28:21
Reporting Period:
2015-07-28
Filing Date:
2015-07-29
Accepted Time:
2015-07-29 17:28:21
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1437402 Ardelyx Inc. ARDX Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1611193 W Jeffrey Jacobs C/O Ardelyx, Inc.
34175 Ardenwood Blvd, Suite 200
Fremont CA 94555
Senior Vp, Technical Ops No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-07-28 2,500 $0.54 49,166 No 4 M Direct
Common Stock Acquisiton 2015-07-28 2,500 $20.00 46,666 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2015-07-28 2,500 $0.00 2,500 $0.54
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
56,874 2021-08-11 No 4 M Direct
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 25, 2015.
  2. The option is immediately exercisable in full, but the shares subject thereto vest according to the following schedule: The shares subject to the option vest in 48 successive, equal monthly installments on each monthly anniversary of August 1, 2011, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.